Drug Type Biological products |
Synonyms CT101(CarMell Therapeutics) |
Target |
Mechanism FGFs stimulants(Fibroblast growth factors stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationFast Track (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fractures, Bone | Phase 2 | US | - |